Plandai Biotechnology Income Statement (2009-2016) | PLPL

Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016
Revenue & cost
Revenue 1.19M1.74M1.87M2.11M2.84M2.21M1.93M0.06M1.25M0.11M0.01M0.03M0.03M0.13M0.11M0.07M0.03M0.07M0.02M-0.06M0.04M0.05M0.10M-0.00M0.08M
Cost of Revenue 0.89M1.38M1.51M1.69M2.43M1.85M1.35M1.16M2.64M1.07M0.17M0.04M0.25M0.36M0.16M0.22M0.18M0.20M0.23M0.19M0.17M
Gross Profit 0.30M0.36M0.36M0.42M0.47M0.36M0.57M0.60M0.36M0.18M-0.06M-0.02M0.03M0.13M0.11M-0.29M-0.13M-0.15M-0.16M-0.16M-0.18M-0.09M-0.09M
Operating items
Depreciation & Amortization - Total 119.000.01M0.01M0.04M0.05M0.05M0.05M0.14M0.13M0.12M
Research & Development 274.000.00M0.01M0.00M0.00M0.02M0.38M
Selling, General & Administrative 1.13M0.15M0.18M0.20M0.18M0.19M0.00M833.000.18M0.00M0.02M0.12M-0.05M0.19M0.19M0.18M0.64M0.44M0.51M0.12M0.10M0.19M0.21M
Other Operating Expenses 1.15M0.27M0.25M0.32M0.38M0.34M-0.03M-0.10M0.24M0.06M0.02M2.34M1.31M0.31M0.29M0.26M0.69M0.63M4.96M0.56M0.44M0.44M0.50M
Operating Expenses 2.33M0.48M0.49M0.56M0.06M0.63M0.57M0.01M0.00M0.46M0.06M0.05M2.47M1.26M0.52M0.52M0.67M1.50M1.23M6.01M0.92M0.75M0.83M0.80M
Operating Income -0.72M-0.12M-0.13M-0.15M0.41M-0.27M0.00M-0.01M0.06M-0.28M-0.06M-0.07M-2.43M-1.31M-0.39M-0.41M-0.96M-1.47M-1.16M-5.99M-0.88M-0.70M-0.72M-0.72M
EBIT -0.72M-0.12M-0.13M-0.15M0.41M-0.27M0.00M-0.01M0.06M-0.28M-0.06M-0.07M-2.43M-1.31M-0.39M-0.41M-0.96M-1.47M-1.16M-5.99M-0.88M-0.70M-0.72M-0.72M
Non-operating items
Non Operating Investment Income 0.08M-0.17M0.07M
Interest & Investment Income -0.26M-0.02M-0.09M-0.02M
Other Non Operating Income 0.06M-0.11M0.06M-0.00M-268.000.00M410.00410.000.13M-0.25M-0.22M0.15M0.34M0.33M-0.07M-0.07M
Non Operating Income -843.00-0.00M
Net income details
EBT -0.99M-0.09M-0.09M-0.11M0.41M-0.27M0.02M0.02M-0.04M-0.37M-0.06M-0.07M-2.43M-1.31M-0.42M-0.37M-1.03M-1.59M-1.29M-6.29M-1.08M-1.02M-1.10M1.02M
Profit After Tax 0.53M0.16M-0.09M-0.18M1.26M0.29M0.08M-0.01M0.06M-0.31M-0.06M-0.07M-2.43M-1.27M-0.42M-0.44M-1.03M-0.64M-1.29M-6.27M18.22M-1.19M-0.75M-1.09M7.76M1.11M
Income from Non-Controlling Interests 0.01M-0.08M-0.11M-0.11M-0.33M0.03M-0.10M-0.12M0.11M-0.06M-0.08M0.09M
Income from Continuing Operations -0.99M-0.09M-0.09M-0.11M0.41M-0.27M0.02M0.02M-0.04M-0.37M-0.06M-0.07M-2.43M-1.31M-0.42M-0.37M-1.03M-1.59M-1.29M-6.29M-1.08M-1.02M-1.10M1.02M
Consolidated Net Income -0.99M-0.09M-0.09M-0.11M0.41M-0.27M0.02M0.02M-0.04M-0.37M-0.06M-0.07M-2.43M-1.31M-0.42M-0.37M-1.03M-1.59M-1.29M-6.29M-1.08M-1.02M-1.10M1.02M
Income towards Parent Company -0.99M-0.09M-0.09M-0.11M0.41M-0.27M0.02M0.02M-0.04M-0.37M-0.06M-0.07M-2.43M-1.31M-0.42M-0.37M-1.03M-1.59M-1.29M-6.29M-1.08M-1.02M-1.10M1.02M
Net Income towards Common Stockholders -0.99M-0.09M-0.09M-0.11M0.41M-0.27M0.02M0.02M-0.04M-0.37M-0.06M-0.07M-2.43M-1.31M-0.42M-0.37M-1.03M-1.59M-1.29M-6.29M-1.08M-1.02M-1.10M1.02M
Additional items
EPS (Basic) -173.03-0.01-0.01-0.010.01M-0.030.010.000.000.000.000.00-0.02-0.01-0.010.00-0.01-0.01-0.01-0.04-0.01-0.01-0.010.00
Shares Outstanding (Weighted Average) 0.01M10.78M10.78M10.78M80.0011.29M10.0076.00M76.00M76.00M76.00M81.71M104.41M96.32M110.90M110.90M110.90M132.61M133.66M140.85M70.00164.52M166.97M175.66M30.00252.35M
EBITDA -0.72M-0.12M0.06M-0.15M0.41M-0.27M0.00M-0.01M0.06M-0.28M-0.06M-0.07M-2.43M-1.24M-0.31M-0.33M-0.57M-0.88M-1.41M-6.01M18.35M-0.74M-0.36M-1.09M6.17M-1.22M
Interest Expenses -0.03M-0.04M-0.03M-0.02M-0.02M-0.02M0.07M424.000.03M0.03M0.07M0.12M0.13M0.30M-0.31M0.32M0.38M-0.48M